Tianjin Med J ›› 2018, Vol. 46 ›› Issue (8): 828-831.doi: 10.11958/20180264

Previous Articles     Next Articles

A case of blastic plasmacytoid dendritic cell neoplasm

NIU Hai-yue, CAO Qiu-ying, QI Wei-wei, WANG Yi-hao, JIANG Hui-juan, WANG Hua-quan, SHAO Zong-hong   

  1. Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China
  • Received:2018-02-22 Revised:2018-06-27 Published:2018-08-15 Online:2018-08-23
  • Contact: Hai-Yue NIU E-mail:369210478@qq.com

Abstract:  Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic neoplasm with high malignancy and rapid progression. BPDCN is sensitive to chemotherapy, but it is prone to relapse and drug resistance, and the survival time is short. We report a case of BPDCN hospitalized in our department. In this case, the skin lesions were the first manifestation. The diagnosis of BPDCN was confirmed by the skin biopsy. Initially, this patient was sensitive to the lymphoma chemotherapy but the disease relapsed quickly, spreading to the lungs and mediastinum. Then, we treated the patient with myeloid regimen, which was no efficacy. The patient eventually died with an overall survival of 17 months.

Key words: hematologic neoplasms, leukemia, myeloid, acute, blastic plasmacytoid dendritic cell neoplasm, diagnosis, treatment